Suchergebnisse - "Jamieson, Stephen Mf"

PubPharm (18)

1

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

enthalten in: JCI insight | 2023

von Jamieson, S. | Tsai, P. | Kondratyev, M. | +32

ErratumFor: JCI Insight. 2018 Aug 23;3(16):. - PMID 30135316

2

Random clonal expansion as a limiting factor in transplantable in vivo CRISPR/Cas9 screens

enthalten in: bioRxiv.org | 2021

von Lee, T. | Hunter, F. | Wilson, W. | +1

3

Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery

enthalten in: Nanomedicine (London, England) | 2019

von Kanamala, M. | Palmer, B. | Jamieson, S. | +2

4

Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery

enthalten in: Nanomedicine | 2019

von Kanamala, M. | Palmer, B. | Jamieson, S. | +2

5

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

enthalten in: JCI insight | 2018

von Jamieson, S. | Tsai, P. | Kondratyev, M. | +32

ErratumIn: JCI Insight. 2023 Feb 22;8(4):. - PMID 36810255

6

Novel pyrazolo[1,5-a]pyridines with improved aqueous solubility as p110α-selective PI3 kinase inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2017

von Kendall, J. | Giddens, A. | Tsang, K. | +14

7

Aspirin-inspired organometallic compounds: Structural characterization and cytotoxicity

enthalten in: Journal of organometallic chemistry | 2017

von Ashraf, A. | Hanif, M. | Kubanik, M. | +4

8

Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand

enthalten in: Journal of inorganic biochemistry | 2016

von Hanif, M. | Moon, S. | Sullivan, M. | +6

9

A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells

enthalten in: Biochemical pharmacology | 2014

von Jamieson, S. | Gu, Y. | Manesh, D. | +14

10

Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3)

enthalten in: Bioorganic & medicinal chemistry | 2014

von Flanagan, J. | Atwell, G. | Heinrich, D. | +8